The AcrAB-TolC pump is involved in multidrug resistance in clinical Shigella flexneri isolates

Microbial Drug Resistance

Volumn 14, Issue 4, 2008, Pages 245-249

  Yang, Haiyan ^a   Duan, Guangcai ^a   Zhu, Jingyuan ^a   Lv, Ruili ^a   Xi, Yuanlin ^a   Zhang, Weidong ^a   Fan, Qingtang ^b   Zhang, Meixi ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Henan Key Laboratory of Fine Chemicals   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 NAPHTHYLAMINE; ACRAB TOLC PROTEIN; AMPICILLIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CARRIER PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; PHENYLARGINYL BETA NAPHTHYLAMIDE; PIPEMIDIC ACID; TETRACYCLINE; TOLC PROTEIN; UNCLASSIFIED DRUG;

ACRA GENE; ACRAB TOLC GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; DRUG ACCUMULATION; DYSENTERY; GENE EXPRESSION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SHIGELLA FLEXNERI; SHIGELLOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TOLC GENE;

BACTERIAL PROTEINS; CARRIER PROTEINS; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; RNA, MESSENGER; SHIGELLA FLEXNERI; UP-REGULATION;

SHIGELLA FLEXNERI;

EID: 57749183062     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2008.0847     Document Type: Article

References (30)

1. Alekshun, M.N., and S.B. Levy. 1997. Regulation of chromosomally mediated antibiotic resistance: the mar regulon. Antimicrob. Agents. Chemother. 41:2067-2075.
2. Baucheron, S., H. Imberechts, E. Chaslus-Dancla, and A. Cloeckaert. 2002. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204. Microb. Drug. Resist. 8:281-289.
3. Chollet, R., J. Chevalier, A. Bryskier, and J.M. Pagès. 2004. The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob. Agents. Chemother. 48:3621-3624.
4. Chu, C., L.H. Su, C.H. Chu, S. Baucheron, A. Cloeckaert, and C.H. Chiu. 2005. Resistance to fluoroquinolones linked to gyrA and parC mutations and overexpression of acrAB efflux pump in Salmonella enterica serotype choleraesuis. Microb. Drug. Resist. 11:248-253.
5. Deguchi, T., A. Fukuoka, M. Yasuda, M. Nakano, S. Ozeki, E. Kanematsu, Y. Nishino, S. Ishihara, Y. Ban, and Y. Kawada. 1997. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinoloneresistant clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents. Chemother. 41:699-701.
6. Edgar, R., and E. Bibi. 1997. MdfA: an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J. Bacteriol. 179:2274-2280.
7. Fralick, J.A. 1996. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J. Bacteriol. 178:5803-5805.
8. Friedman, S.M., T. Lu, and K. Drlica. 2001. Mutation in the DNA gyrase A gene of Escherichia coli that expands the quinolone resistance-determining region. Antimicrob. Agents. Chemother. 45:2378-2380.
9. Jacoby, G.A. 2005. Mechanisms of resistance to quinolones. Clin. Infect. Dis. 41:120-127.
10. Ghosh, A.S., J. Ahamed, K.K. Chauhan, and M. Kundu. 1998. Involvement of an efflux system in high-level fluoroquinolone resistance of S. flexneri dysenteriae. Biochem. Biophys. Res. Commun. 242:54-56.
11. Giske, C.G., L. Buarø, A. Sundsfjord, and B. Wretlind. 2008. Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of pseudomonas aeruginosa. Microb. Drug. Resist. 14:23-30.
12. Huang, Z.J., L.J. Wang, and Y. Dong. 2002. Analysis on the character of the death because of infection disease in the disease surveillance 2000, China. Dis. Surveill. 17:265-266.
13. Iversen, J., D. Sandvang, A. Srijan, P.D. Cam, and A. Dalsgaard. 2003. Characterization of antimicrobial resistance, plasmids, and gene cassettes in Shigella spp. from patients in Vietnam. Microb. Drug. Resist. 9:17-24.
14. Levy, S.B. 1992. Active efflux mechanisms for antibacterial resistance. Antimicrob. Agents. Chemother. 36:695-699.
15. Lomovskaya, O., and K. Lewis. 1992. emr, an Escherichia coli locus for multidrug resistance. Proc. Natl. Acad. Sci. U.S.A. 89:8938-8942.
16. Maneewannakul, K., and S.B. Levy. 1996. Identification of mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents. Chemother. 40:1695-1698.
17. Mazzariol, A., Y. Tokue, T.M. Kanegawa, G. Cornaglia, and H. Nikaido. 2000. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob. Agents. Chemother. 44:3441-3443.
18. Mead, P.S., L. Slutsker, P.M. Griffin, and R.V. Tauxe. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607-625.
19. [NCCLS] National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th ed. NCCLS document M2-A6. National Committee for Clinical Laboratory Standards, Wayne, PA.
20. Nikaido, H. 1996. Multidrug efflux pumps of Gram-negative bacteria. J. Bacteriol. 178:5853-5859.
21. Okusu, H., D. Ma, and H. Nikaido. 1996. AcrAB effux pumps plays a major role in the antibiotic resistance phenotype of mutiple-antibiotic- resistance (Mar) mutants. J. Bacteriol. 178:306-308.
22. Opintan, J., and M.J. Newman. 2007. Distribution of serogroups and serotypes of multiple drug resistant shigella isolates. Ghana. Med. J. 41:8-29.
23. Paulsen, I.T., M.K. Sliwinski, and M.H. Saler, Jr. 1998. Microbiol genome analyses: global comparisons of transport capabilities based on phylogenies, bioenergetics and substrate specificities. J. Mol. Biol. 277:573-592.
24. Piddock, L.J., D.G. White, K. Gensberg, L. Pumbwe, and D.J. Griggs. 2000. Evidence for an efflux mediating multiple antibiotic resistant in Salmonella enterica serovar typhimurium. Antimicrob. Agents. Chemother. 44:3118-3121.
25. Poirel, L., T.V. Nguyen, A. Weintraub, C. Leviandier, and P. Nordmann. 2006. Plasmid-mediated quinolone resistance determinant qnrS in Enterobacter cloacae. Clin. Microbiol. Infect. 12:1021-1023.
26. Reller, M.E., J.M. Nelson, K. Mølbak, D.M. Ackman, D.J. Schoonmaker-Bopp, T.P. Root, and E.D. Mintz. 2006. A large, multiple-restaurant outbreak of infection with Shigella flexneri serotype 2a traced to tomatoes. Clin. Infect. Dis. 42:163-169.
27. Salam, M.A., and M.L. Bennish. 1991. Antimicrobial therapy for shigellosis. Rev. Infect. Dis. 13:332-341.
28. Sivapalasingam, S., J.M. Nelson, K. Joyce, M. Hoekstra, F.J. Angulo, and E.D. Mintz. 2003. Growing antimicrobial resistance of Shigella isolates. J. Antimicrob. Chemother. 51:427-429.
29. Sivapalasingam, S., J.M. Nelson, K. Joyce, M. Hoekstra, F.J. Angulo, and E.D. Mintz. 2006. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob. Agents. Chemother. 50:49-54.
30. Taneja, N. 2007. Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigella in India. J. Clin. Microbiol. 45:678-679.